Stock AURX NUO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Nuo Therapeutics, Inc.

Equities

AURX

US67059V2097

Market Closed - OTC Markets
Other stock markets
 12:58:58 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.33 USD -10.81% Intraday chart for Nuo Therapeutics, Inc. +3.48% -40.00%
May. 20 Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding CI
May. 15 Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Insider Buy: Nuo Therapeutics
MT
Insider Buy: Nuo Therapeutics
MT
Nuo Therapeutics, Inc. Announces Board Changes
CI
Nuo Therapeutics, Inc. Appoints David E. Jorden as Chief Executive Officer and Chief Financial Officer
CI
Nuo Therapeutics, Inc. Announces Board Changes
CI
Nuo Therapeutics Announces Senior Management Changes
CI
Nuo Therapeutics Announces Appointment of Shaun Martin as Chief Restructuring Officer Effective December 15, 2015
CI
Nuo Therapeutics, Inc. Announces Management Changes
CI
Nuo Therapeutics, Inc. Announces Resignation of Richard Kent from the Board of Directors
CI
Cytomedix, Inc. will Change its Name to Nuo Therapeutics, Inc
CI
Cytomedix, Inc. Appoints Andrew Cohen as Vice President of Marketing
CI
Cytomedix Announces Senior Management Appointments
CI
Cytomedix, Inc. Announces Board Changes
CI
Cytomedix, Inc. Announces Executive Changes
CI
Cytomedix Inc. Announces Executive Changes
CI
Cytomedix Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AURX Stock
  4. News Nuo Therapeutics, Inc.
  5. Insiders